OTC:ANEB | Profit Breakdown | Anebulo Pharmaceuticals, Inc.

Complete filed revenue-to-profit bridge showing gross profit, operating income, pre-tax income and net income.

Available history
2020-09-30 to 2025-12-31
Data captured

Historical Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2025-12-31-$2.62M-$2M
2025-09-30-$2.26M-$2.16M
2025-06-30-$2.33M-$2.14M
2025-03-31-$1.89M-$1.68M
2024-12-31-$2.59M-$2.46M
2024-09-30-$2.41M-$2.2M
2024-06-30-$1.34M-$1.35M
2024-03-31-$1.66M-$1.65M
2023-12-31-$2.76M-$2.72M
2023-09-30-$2.54M-$2.48M
2023-06-30-$2.49M-$2.5M
2023-03-31-$2.86M-$2.8M
2022-12-31-$3.81M-$3.83M
2022-09-30-$2.61M-$2.61M
2022-06-30-$2.33M-$2.32M
2022-03-31-$1.88M-$1.88M
2021-12-31-$1.07M-$1.07M
2021-09-30-$1.55M-$1.55M-$1.55M
2021-06-30-$2.48M-$2.47M-$29.11M
2021-03-31-$552,131.00-$555,832.00-$555,832.00
2020-12-31-$324,571.00-$328,604.00
2020-09-30-$252,346.00-$256,379.00

Annual Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2025-06-30-$9.22M-$8.48M
2024-06-30-$8.31M-$8.2M
2023-06-30-$11.78M-$11.73M
2022-06-30-$6.83M-$6.83M
2021-06-30-$3.61M-$3.61M-$30.25M